A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

References

Page 1

	Year	Citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors George D. Demetri, Margaret von Mehren, Charles D. Blanke, New England Journal of Medicine	2002	4.4K
Optimal two-stage designs for phase II clinical trials Richard Simon Controlled Clinical Trials Clinical Trial ManagementClinical TrialsRandomized Controlled TrialBiostatisticsDrug Trial	1989	3.6K
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer Charles E. Geyer, John Forster, Deborah Lindquist, New England Journal of Medicine	2006	3.4K
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer William P. McGuire, William J. Hoskins, Mark F. Brady, New England Journal of Medicine	1996	2.9K
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel, New England Journal of Medicine	2006	2.6K
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer New England Journal of Medicine	2005	1.6K
A potent specific pure antiestrogen with clinical potential. A. E. Wakeling, Michael Dukes, Jean Bowler PubMed Molecular PharmacologyMedicinal ChemistryAntiestrogenic PotencyPure Antiestrogenic ActivityHormonal Contraceptive	1991	1.1K
Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results M. Piccart JNCI Journal of the National Cancer Institute	2000	1K
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study Robert A. Burger, Michael W. Sill, Bradley J. Monk, Journal of Clinical Oncology	2007	878

Page 1